Regulation of gap-junction protein connexin 43 by β-adrenergic receptor stimulation in rat cardiomyocytes

Acta Pharmacologica Sinica

Volumn 30, Issue 7, 2009, Pages 928-934

  Xia, Yi ^a,c   Gong, Kai Zheng ^b,c,d   Xu, Ming ^b,c   Zhang, You Yi ^b,c   Guo, Ji Hong ^a,c   Song, Yao ^b,c   Zhang, Ping ^a,c  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d Affiliated Hospital of Yangzhou University   (China)

Author keywords

adrenergic receptor; Cardiac myocyte; Connexin43; Gap junction

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; CONNEXIN 43; CYCLIC AMP DEPENDENT PROTEIN KINASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PERTUSSIS TOXIN; PROPRANOLOL;

ANIMAL CELL; ARTICLE; CELL COMMUNICATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GAP JUNCTION; HEART CELL CULTURE; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CONNEXIN 43; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GAP JUNCTIONS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; IMIDAZOLES; ISOPROTERENOL; MYOCYTES, CARDIAC; PERTUSSIS TOXIN; PROPRANOLOL; PROTEIN ISOFORMS; PROTEIN PHOSPHATASE 2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 67651177622     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.92     Document Type: Article

References (34)

1. Kanno S, Safftz JE. The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc Pathol 2001; 10: 169-77.
2. Sáez JC, Berthoud VM, Brañes MC, Martínez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003; 83: 1359-400.
3. Söhl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc Res 2004; 62: 228-32.
4. Beauchamp P, Choby C, Desplantez T, de Peyer K, Green K, Yamada KA, et al. Electrical propagation in synthetic ventricular myocyte strands from germline connexin43 knockout mice. Circ Res 2004; 95: 170-8.
5. Gutstein DE, Morley GE, Vaidya D, Liu F, Chen FL, Stuhlmann H, et al. Heterogeneous expression of gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation 2001; 104: 1194-9.
6. Bao X, Altenberg GA, Reuss L. Mechanism of regulation of the gap junction protein connexin 43 by protein kinase C-mediated phosphorylation. Am J Physiol Cell Physiol 2004; 286: C647-C654.
7. Huang XD, Sandusky GE, Zipes DP. Heterogeneous loss of connexin43 protein in ischemic dog hearts. J Cardiovasc Electrophysiol 1999; 10: 79-91.
8. Wang X, Gerdes AM. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs, III: intercalated disc remodeling. J Mol Cell Cardiol 1999; 31: 333-43.
9. Peters NS, Green CR, Poole-Wilson PA, Severs NJ. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 1993; 88: 864-75.
10. 3-adrenergic receptor functional expression following chronic stimulation with noradrenaline in neonatal rat cardiomyocytes. J Pharmacol Exp Ther 2006; 316: 392-402.
11. Rojas Gomez DM, Schulte JS, Mohr FW, Dhein S. Alpha-1-adrenoceptor subtype selective regulation of connexin 43 expression in rat cardiomyocytes. Naunyn-Schmiedeberg's Arch Pharmacol 2008; 377: 77-85
12. 2-adrenoceptor responsiveness and prevents ventricular fibrillation in animals susceptible to sudden death. Am J Physiol Heart Circ Physiol 2006; 290: H2590-9.
13. Desaphy JF, De Luca A, Camerino DC. Blockade by cAMP of native sodium channels of adult rat skeletal muscle fibers. Am J Physiol 1998; 275: 1465-72.
14. Liao W, Wang S, Han C, Zhang Y. 14-3-3 proteins regulate glycogen synthase 3beta phosphorylation and inhibit cardiomyocyte hypertrophy. FEBS J 2005; 272: 1845-54.
15. El-fouly MH, Trosko JE, Chang CC. Scrape-loading and dye transfer: a rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res 1987; 168: 422-30.
16. Johnson M. Molecular mechanisms of beta (2)-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol 2006; 117: 18-24.
17. Chesley A, Lundberg MS, Asai T, Xiao RP, Ohtani S, Lakatta EG, et al. The beta 2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-dependent coupling to phosphatidylinositol 3'-Kinase. Circ Res 2000; 87: 1172-9.
18. Bokník P, Fockenbrock M, Neumann J, Knapp J, Linck B, Lüss H, et al. Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation. Naunyn Schmiedebergs Arch Pharmacol 2000; 362: 222-31.
19. Pullar CE, Chen J, Isseroff RR. PP2A activation by beta2-adrenergic receptor agonists: novel regulatory mechanism of keratinocyte migration. J Biol Chem 2003; 278: 22555-62.
20. Zipes DP. Sympathetic stimulation and arrhythmias. N Engl J Med 1991; 325: 656-7.
21. Dhein S, Polontchouk L, Salameh A, Haefiger JA. Pharmacological modulation and differential regulation of the cardiac gap junction proteins connexin 43 and connexin 40. Biol Cell 2002; 94: 409-22.
22. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of β-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004; 125: 2309-21.
23. Lemaitre RN, Siscovick DS, Psaty BM, Pearce RM, Raghunathan TE, Whitsel EA, et al. Inhaled β2 adrenergic receptor agonists and primary cardiac arrest. Am J Med 2002; 113: 711-6.
24. Kallergis EM, Manios EG, Kanoupakis EM, Schiza SE, Mavrakis HE, Klapsinos NK, et al. Acute electrophysiologic effects of inhaled salbutamol in humans. Chest 2005; 127: 2057-63.
25. 2-selective agonist. J Cardiovasc Electrophysiol 2004; 15: 316-22.
26. Shah MM, Martinez AM, Fletcher WH. The connexin43 gap junction protein is phosphorylated by protein kinase A and protein kinase C: in vivo and in vitro studies. Mol Cell Biochem 2002; 238: 57-68.
27. Somekawa S, Fukuhara S, Nakaoka Y, Fujita H, Saito Y, Mochizuki N. Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ Res 2005; 97: 655-62.
28. Tong H, Bernstein D, Steenbergen C. The role of beta-adrenergic receptor signaling in cardioprotection. FASEB J 2005; 19: 983-5.
29. Dhein S, Larsen BD, Petersen JS, Mohr FW. Effects of the new antiarrhythmic peptide ZP123 on epicardial activation and repolarization pattern. Cell Commun Adhes 2003; 10: 371-8.
30. Favre B, Turowski P, Hemmings BA. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J Biol Chem 1997; 272: 13856-63.
31. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, et al. Cardiac malformation in neonatal mice lacking connexin43. Science 1995; 267: 1831-4.
32. Ya J, Erdtsieck-Ernste EB, de Boer PA, van Kempen MJ, Jongsma H, Gros D, et al. Heart defects in connexin43-defcient mice. Circ Res 1998; 82: 360-6.
33. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 2001; 88: 333-9.
34. Lerner DL, Yamada KA, Schuessler RB, Safftz JE. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in C×43-defcient mice. Circulation 2000; 101: 547-52.